Pathogenic or likely pathogenic variants of the patients with congenital hyperinsulinism.
Gene . | Transcript . | Allele . | Protein . | In silico analyses . | Carriers (n) . | Ref. . |
---|---|---|---|---|---|---|
ABCC8 | NM_000352.4 | c.560T>A | p.(Val187Asp) | P | 24 | (9) |
c.1576C>Ta | p.(Arg526Cys) | P | 1 | (4) | ||
c.3280_3281dela | p.(Lys1094Glufs*19) | P | 1 | Novel | ||
c.3336dup | p.(Glu1113*) | P | 1 | (21) | ||
c.3551C>T | p.(Ala1184Val) | P | 1 | (22) | ||
c.3640C>T | p.(Arg1214Trp) | P | 1 | (23) | ||
c.4307G>A | p.(Arg1436Gln) | P | 1 | (24, 25) | ||
c.4406G>T | p.(Gly1469Val) | P | 1 | (26) | ||
c.4369G>Ab | p.(Ala1457Thr) | P | 1 | (27) | ||
c.4372C>A | p.(Gln1458Lys) | P | 1 | Novel | ||
c.4411G>Ab | p.(Asp1471Asn) | P | 2 | (28, 29) | ||
c.4451G>A | p.(Gly1484Glu) | P | 1 | (30) | ||
c.4516G>A | p.(Glu1506Lys) | P | 14 | (10) | ||
c.4547A>C | p.(Glu1516Ala) | LP | 1 | Novel | ||
c.4649T>Ab | p.(Val1550Asp) | P | 1 | (27) | ||
c.4651C>G | p.(Leu1551Val) | P | 2 | (27) | ||
KCNJ11 | NM_000525.3 | c.201G>Cc | p.(Lys67Asn) | P | 2 | (27) |
c.539C>T | p.(Thr180Ile) | P | 2 | Novel | ||
C>T c | -54 bases proximal of the translation initiation site | P | 1 | (27) | ||
GLUD1 | NM_005271.4 | c.965G>A | p.(Arg322His) | P | 4 | (31) |
c.1493C>T | p.(Ser498Leu) | P | 2 | (32) | ||
GCK | NM_033508.1 | c.193A>G | p.(Thr65Ala) | P | 1 | Novel |
c.638A>G | p.(Tyr213Cys) | P | 1 | (33) | ||
SLC16A1 | NM_003051.3 | c.-391_-390ins25bp | p.? | P | 2 | (34) |
c.-202G>A | p.? | P | 1 | (34) | ||
HNF4A | NM_000457.4 | c.992G>A | p.(Arg331His) | P | 1 | (35) |
Gene . | Transcript . | Allele . | Protein . | In silico analyses . | Carriers (n) . | Ref. . |
---|---|---|---|---|---|---|
ABCC8 | NM_000352.4 | c.560T>A | p.(Val187Asp) | P | 24 | (9) |
c.1576C>Ta | p.(Arg526Cys) | P | 1 | (4) | ||
c.3280_3281dela | p.(Lys1094Glufs*19) | P | 1 | Novel | ||
c.3336dup | p.(Glu1113*) | P | 1 | (21) | ||
c.3551C>T | p.(Ala1184Val) | P | 1 | (22) | ||
c.3640C>T | p.(Arg1214Trp) | P | 1 | (23) | ||
c.4307G>A | p.(Arg1436Gln) | P | 1 | (24, 25) | ||
c.4406G>T | p.(Gly1469Val) | P | 1 | (26) | ||
c.4369G>Ab | p.(Ala1457Thr) | P | 1 | (27) | ||
c.4372C>A | p.(Gln1458Lys) | P | 1 | Novel | ||
c.4411G>Ab | p.(Asp1471Asn) | P | 2 | (28, 29) | ||
c.4451G>A | p.(Gly1484Glu) | P | 1 | (30) | ||
c.4516G>A | p.(Glu1506Lys) | P | 14 | (10) | ||
c.4547A>C | p.(Glu1516Ala) | LP | 1 | Novel | ||
c.4649T>Ab | p.(Val1550Asp) | P | 1 | (27) | ||
c.4651C>G | p.(Leu1551Val) | P | 2 | (27) | ||
KCNJ11 | NM_000525.3 | c.201G>Cc | p.(Lys67Asn) | P | 2 | (27) |
c.539C>T | p.(Thr180Ile) | P | 2 | Novel | ||
C>T c | -54 bases proximal of the translation initiation site | P | 1 | (27) | ||
GLUD1 | NM_005271.4 | c.965G>A | p.(Arg322His) | P | 4 | (31) |
c.1493C>T | p.(Ser498Leu) | P | 2 | (32) | ||
GCK | NM_033508.1 | c.193A>G | p.(Thr65Ala) | P | 1 | Novel |
c.638A>G | p.(Tyr213Cys) | P | 1 | (33) | ||
SLC16A1 | NM_003051.3 | c.-391_-390ins25bp | p.? | P | 2 | (34) |
c.-202G>A | p.? | P | 1 | (34) | ||
HNF4A | NM_000457.4 | c.992G>A | p.(Arg331His) | P | 1 | (35) |
Abbreviations: P, pathogenic; LP, likely pathogenic.
aThe variants are compound heterozygous.
bThe variant is compound heterozygous for the founder mutation ABCC8/c.560T>A, p.(Val187Asp).
cThe variants are compound heterozygous.
Pathogenic or likely pathogenic variants of the patients with congenital hyperinsulinism.
Gene . | Transcript . | Allele . | Protein . | In silico analyses . | Carriers (n) . | Ref. . |
---|---|---|---|---|---|---|
ABCC8 | NM_000352.4 | c.560T>A | p.(Val187Asp) | P | 24 | (9) |
c.1576C>Ta | p.(Arg526Cys) | P | 1 | (4) | ||
c.3280_3281dela | p.(Lys1094Glufs*19) | P | 1 | Novel | ||
c.3336dup | p.(Glu1113*) | P | 1 | (21) | ||
c.3551C>T | p.(Ala1184Val) | P | 1 | (22) | ||
c.3640C>T | p.(Arg1214Trp) | P | 1 | (23) | ||
c.4307G>A | p.(Arg1436Gln) | P | 1 | (24, 25) | ||
c.4406G>T | p.(Gly1469Val) | P | 1 | (26) | ||
c.4369G>Ab | p.(Ala1457Thr) | P | 1 | (27) | ||
c.4372C>A | p.(Gln1458Lys) | P | 1 | Novel | ||
c.4411G>Ab | p.(Asp1471Asn) | P | 2 | (28, 29) | ||
c.4451G>A | p.(Gly1484Glu) | P | 1 | (30) | ||
c.4516G>A | p.(Glu1506Lys) | P | 14 | (10) | ||
c.4547A>C | p.(Glu1516Ala) | LP | 1 | Novel | ||
c.4649T>Ab | p.(Val1550Asp) | P | 1 | (27) | ||
c.4651C>G | p.(Leu1551Val) | P | 2 | (27) | ||
KCNJ11 | NM_000525.3 | c.201G>Cc | p.(Lys67Asn) | P | 2 | (27) |
c.539C>T | p.(Thr180Ile) | P | 2 | Novel | ||
C>T c | -54 bases proximal of the translation initiation site | P | 1 | (27) | ||
GLUD1 | NM_005271.4 | c.965G>A | p.(Arg322His) | P | 4 | (31) |
c.1493C>T | p.(Ser498Leu) | P | 2 | (32) | ||
GCK | NM_033508.1 | c.193A>G | p.(Thr65Ala) | P | 1 | Novel |
c.638A>G | p.(Tyr213Cys) | P | 1 | (33) | ||
SLC16A1 | NM_003051.3 | c.-391_-390ins25bp | p.? | P | 2 | (34) |
c.-202G>A | p.? | P | 1 | (34) | ||
HNF4A | NM_000457.4 | c.992G>A | p.(Arg331His) | P | 1 | (35) |
Gene . | Transcript . | Allele . | Protein . | In silico analyses . | Carriers (n) . | Ref. . |
---|---|---|---|---|---|---|
ABCC8 | NM_000352.4 | c.560T>A | p.(Val187Asp) | P | 24 | (9) |
c.1576C>Ta | p.(Arg526Cys) | P | 1 | (4) | ||
c.3280_3281dela | p.(Lys1094Glufs*19) | P | 1 | Novel | ||
c.3336dup | p.(Glu1113*) | P | 1 | (21) | ||
c.3551C>T | p.(Ala1184Val) | P | 1 | (22) | ||
c.3640C>T | p.(Arg1214Trp) | P | 1 | (23) | ||
c.4307G>A | p.(Arg1436Gln) | P | 1 | (24, 25) | ||
c.4406G>T | p.(Gly1469Val) | P | 1 | (26) | ||
c.4369G>Ab | p.(Ala1457Thr) | P | 1 | (27) | ||
c.4372C>A | p.(Gln1458Lys) | P | 1 | Novel | ||
c.4411G>Ab | p.(Asp1471Asn) | P | 2 | (28, 29) | ||
c.4451G>A | p.(Gly1484Glu) | P | 1 | (30) | ||
c.4516G>A | p.(Glu1506Lys) | P | 14 | (10) | ||
c.4547A>C | p.(Glu1516Ala) | LP | 1 | Novel | ||
c.4649T>Ab | p.(Val1550Asp) | P | 1 | (27) | ||
c.4651C>G | p.(Leu1551Val) | P | 2 | (27) | ||
KCNJ11 | NM_000525.3 | c.201G>Cc | p.(Lys67Asn) | P | 2 | (27) |
c.539C>T | p.(Thr180Ile) | P | 2 | Novel | ||
C>T c | -54 bases proximal of the translation initiation site | P | 1 | (27) | ||
GLUD1 | NM_005271.4 | c.965G>A | p.(Arg322His) | P | 4 | (31) |
c.1493C>T | p.(Ser498Leu) | P | 2 | (32) | ||
GCK | NM_033508.1 | c.193A>G | p.(Thr65Ala) | P | 1 | Novel |
c.638A>G | p.(Tyr213Cys) | P | 1 | (33) | ||
SLC16A1 | NM_003051.3 | c.-391_-390ins25bp | p.? | P | 2 | (34) |
c.-202G>A | p.? | P | 1 | (34) | ||
HNF4A | NM_000457.4 | c.992G>A | p.(Arg331His) | P | 1 | (35) |
Abbreviations: P, pathogenic; LP, likely pathogenic.
aThe variants are compound heterozygous.
bThe variant is compound heterozygous for the founder mutation ABCC8/c.560T>A, p.(Val187Asp).
cThe variants are compound heterozygous.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.